[CNP_P16] Poster Session 16

[CNP-P16-2] Clustering Patients by Depression Symptoms May Predict Treatment Outcomes for Major Depressive Disorder: Patient-level Meta-analysis of Venlafaxine Extended Release Trials

^○Masaki KATO¹, Yuko ASAMI², Dalia WAJSBROT⁴, Matthieu BOUCHER³, Rita PRIETO⁵, Xuemei WANG⁶, Elizabeth PAPPADOPULOS⁴ (1. Department of Neuropsychiatry, Kansai Medical University, 2. Pfizer Japan Inc., Tokyo, Japan, 3. Pfizer Canada Inc., Kirkland, QC, Canada and McGill University, Montréal, QC, Canada, 4. Pfizer Inc., New York, NY, USA, 5. Pfizer GEP SLU, Madrid, Spain , 6. Syneos Health Inc., Raleigh)